Search results
Author(s):
Giacomo Buso
,
Claudia Agabiti-Rosei
,
Matteo Lemoli
,
et al
Added:
1 year ago
Author(s):
Ahmed Elamin
,
Mustafa Abdimalik
,
Mohanad Abdelrahim
,
et al
Added:
1 week ago
Author(s):
Johanna McChord
,
Astrid Hubert
,
Udo Sechtem
,
et al
Added:
1 year ago
Author(s):
Filippo Gurgoglione
,
Giampaolo Niccoli
Added:
12 months ago
Author(s):
Maria Lorenza Muiesan
,
Matteo Lemoli
Added:
2 weeks ago
Author(s):
Shozo Sueda
,
Tomoki Sakaue
Added:
1 year ago
Author(s):
Harriette Van Spall
,
Luke Laffin
Added:
7 months ago
ACC 25 - ADVANCE-HTN shows lorundrostat, an aldosterone synthase inhibitor, effectively lowered 24-hour blood pressure in patients with uncontrolled and true resistant hypertension.Late-breaker discussion host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Dr Luke Laffin (Cleveland Clinic, Cleveland, OH, US) to discuss the key findings from the ADVANCE-HTN trial…
View more
Angela Maas
Research Area(s) / Expertise:
Author
Mark Petrie
Research Area(s) / Expertise:
Job title: Professor/Honorary Consultant (Institute of Cardiovascular & Medical Sciences)
Author